The frequency of anti-FHL1 autoantibodies in our cohort of patients with IIM is similar to the original report of anti-FHL1 autoantibodies but higher than in a more recently published study [14]. The gene discussed is FHL1; the disease is acquired idiopathic inflammatory myopathy.